OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SOCS5 contributes to temozolomide resistance in glioblastoma by regulating Bcl-2-mediated autophagy
Jie Yu, Lin Han, Feng Yang, et al.
Bioengineered (2022) Vol. 13, Iss. 6, pp. 14125-14137
Open Access | Times Cited: 9

Showing 9 citing articles:

Autophagy and cancer drug resistance in dialogue: Pre-clinical and clinical evidence
Yi Qin, Milad Ashrafizadeh, Vera Mongiardini, et al.
Cancer Letters (2023) Vol. 570, pp. 216307-216307
Closed Access | Times Cited: 145

Autophagy in brain tumors: molecular mechanisms, challenges, and therapeutic opportunities
Jiarui Zhang, Jin‐an Zhang, Yang Chen
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access

Crebanine, an aporphine alkaloid, induces cancer cell apoptosis through PI3K-Akt pathway in glioblastoma multiforme
Poh‐Shiow Yeh, Chien-Te Liu, Chia‐Ying Yu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4

Characterization and functional analysis of SOCS9 from orange-spotted grouper (Epinephelus coioides) during virus infection
Junxi Chen, Zhaofeng Chen, Yi Li, et al.
Fish & Shellfish Immunology (2024) Vol. 146, pp. 109424-109424
Closed Access | Times Cited: 3

Autophagy machinery in glioblastoma: The prospect of cell death crosstalk and drug resistance with bioinformatics analysis
Yi Qin, Shengjun Xiong, Jun Ren, et al.
Cancer Letters (2023) Vol. 580, pp. 216482-216482
Closed Access | Times Cited: 6

Development of In Vitro Assays for Advancing Radioimmunotherapy against Brain Tumors
Yohan Walter, Anne M. Hubbard, Allie Benoit, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1796-1796
Open Access | Times Cited: 5

The PYK2 inhibitor PF-562271 enhances the effect of temozolomide on tumor growth in a C57Bl/6-Gl261 mouse glioma model
Jescelica Ortiz-Rivera, Rebeca E. Nuñez, Yuriy V. Kucheryavykh, et al.
Journal of Neuro-Oncology (2023) Vol. 161, Iss. 3, pp. 593-604
Open Access | Times Cited: 2

The signature of immune-subtype specific driving transcription factors suggest potential drugs for refractory glioblastoma.
Wenjin Chen, Lihua Chen, Lili Guo, et al.
PubMed (2023) Vol. 13, Iss. 4, pp. 1278-1294
Closed Access | Times Cited: 2

Page 1

Scroll to top